Many of you have raised real issue with the protracted absence of company news. What is really troubling beyond this situation is that if there was any behind the scenes rumblings that the ii-Key vaccine was going to become a reality, big pocket investors would be falling over each other to become stakeholders. The reality is no big purchaser lots, no purchasers, no interest in the professional segment of investor players. This does not bode well at this point. I really wonder if this is a dead cat.
(2)
(1)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links